Filing Details
- Accession Number:
- 0001209191-23-016053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-03 20:00:36
- Reporting Period:
- 2023-03-01
- Accepted Time:
- 2023-03-03 20:00:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1326969 | L Camille Bedrosian | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Evp And Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-01 | 2,663 | $0.00 | 50,601 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-03-01 | 3,881 | $45.25 | 46,720 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares of common stock into which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.
- Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
- Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Billionaire Hedge Funds
